Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3OLANZAPINE

02 3RISPERIDONE

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
APGA Annual Conference
Not Confirmed
arrow
APGA Annual Conference
Not Confirmed

OLANZAPINE

Drug : OLANZAPINE

Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL

Application Number : 200221

Country : US

Patented : No

blank

02

arrow
APGA Annual Conference
Not Confirmed
arrow
APGA Annual Conference
Not Confirmed

RISPERIDONE

Drug : RISPERIDONE

Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL

Application Number : 90839

Country : US

Patented : No

blank

03

arrow
APGA Annual Conference
Not Confirmed
arrow
APGA Annual Conference
Not Confirmed

OLANZAPINE

Drug : OLANZAPINE

Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL

Application Number : 203044

Country : US

Patented : No

blank

04

arrow
APGA Annual Conference
Not Confirmed
arrow
APGA Annual Conference
Not Confirmed

RISPERIDONE

Drug : RISPERIDONE

Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL

Application Number : 77542

Country : US

Patented : No

blank

05

arrow
APGA Annual Conference
Not Confirmed
arrow
APGA Annual Conference
Not Confirmed

OLANZAPINE

Drug : OLANZAPINE

Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL

Application Number : 90881

Country : US

Patented : No

blank

06

arrow
APGA Annual Conference
Not Confirmed
arrow
APGA Annual Conference
Not Confirmed

RISPERIDONE

Drug : RISPERIDONE

Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL

Application Number : 78474

Country : US

Patented : No

blank